Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Blue Water Ventures International Inc (BWVI)

Blue Water Ventures International Inc (BWVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Dr. Neilank Jha Appointed as Executive Chairman and Chief Executive Officer of Psycheceutical Bioscience Inc. ACCESSWIRE - Mon Dec 11, 2023

MIAMI, FL / ACCESSWIRE / December 12, 2023 / Psycheceutical Bioscience, Inc. ("Psycheceutical" or the "Company") (OTC PINK:BWVI), a bioscience company dedicated to developing cutting-edge technologies...

BWVI : 0.0125 (-10.71%)
Psycheceutical Bioscience Launches Wefunder Crowdfunding Campaign for Safer Psychedelic Dosing ACCESSWIRE - Wed Nov 1, 2023

Investors are invited to support Psycheceutical's mission to revolutionize psychedelic medicines by taking part in the company's Wefunder Community Round.

BWVI : 0.0125 (-10.71%)
Psycheceutical Announces Successful First Cohort Dosing; Moves to Dose Escalation in Phase I Trial of NeuroDirect Ketamine for PTSD ACCESSWIRE - Thu Aug 10, 2023

Company's novel NeuroDirectTM topical ketamine formulation to treat PTSD shown to be safe and well-tolerated in first cohort of Phase I trial.

BWVI : 0.0125 (-10.71%)
Psycheceutical Bioscience Announces Completion of PCAOB Audit and Future Corporation Action Strategy ACCESSWIRE - Tue Aug 1, 2023

MIAMI, FL / ACCESSWIRE / August 1, 2023 / Psycheceutical Bioscience, Inc. ("Psycheceutical'' or the "Company") (OTC PINK:BWVI), a bioscience company dedicated to developing cutting-edge technologies for...

BWVI : 0.0125 (-10.71%)
First Patient Dosed in Psycheceutical's Phase I Study Exploring Topical Administration of Ketamine to Treat PTSD ACCESSWIRE - Thu Jul 13, 2023

Psycheceutical's clinical trial program is the first ever to test the topical application of ketamine for use in treating a mental health disorder through the company's NeuroDirect™ delivery system.

BWVI : 0.0125 (-10.71%)
Psycheceutical Completes Acquisition by Blue Water Ventures International Globe Newswire - Thu Jan 20, 2022

Miami, FL, Jan. 20, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Psycheceutical, Inc., a biotechnology company dedicated to the development and...

OTC.VN : 0.340 (-1.45%)
BWVI : 0.0125 (-10.71%)
Blue Water Ventures International, Inc. Signs Non-Binding Letter of Intent to Acquire Psycheceutical, Inc. Globe Newswire - Wed Nov 3, 2021

Miami, FL, Nov. 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Blue Water Ventures International, (OTC: BWVI), has signed a non-binding letter of...

OTC.VN : 0.340 (-1.45%)
BWVI : 0.0125 (-10.71%)
Blue Water Ventures International and Partners Endurance Exploration Group Share Update on the Current 2021 Recovery Season of Steamboat Pulaski Globe NewsWire - Wed Aug 25, 2021

Jacksonville, FL, Aug. 25, 2021 (GLOBE NEWSWIRE) -- via  NewMediaWire --   Blue Water Ventures International, Inc. (OTCPK: BWVI) and joint venture partners Endurance Exploration Group (OTCPK: EXPL)...

BWVI : 0.0125 (-10.71%)
EXPL : 0.0003 (unch)
New Sonar Survey Discovers Large Unsalvaged Sections of SB Pulaski, 1838 Globe NewsWire - Wed Jun 23, 2021

Jacksonville, FL, June 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire   -- Project partners Blue Water Ventures, Inc. (OTCPK: BWVI), Endurance Exploration Group, Inc. (OTCPK:EXPL), and Marex International,...

BWVI : 0.0125 (-10.71%)
EXPL : 0.0003 (unch)
Blue Water Ventures International Signs Extension on Pulaski Recovery Globe NewsWire - Wed Mar 17, 2021

Jacksonville, FL, March 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire   -- Blue Water Ventures International, Inc. (OTCPK:BWVI) and project partner Endurance Exploration Group, Inc (OTC:EXPL) through...

BWVI : 0.0125 (-10.71%)
EXPL : 0.0003 (unch)

Barchart Exclusives

FOMC, Earnings and Other Can't Miss Items This Week Barchart - Sun Apr 28, 2:00PM CDT
This week's earnings are still a strong theme and in addition Non-Farm Payrolls, JOLTs, and the big one, The Fed Funds rate. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot